Published in Transplantation on July 15, 2013
Immune tolerance in liver disease. Hepatology (2014) 1.05
Development of Gene Transfer for Induction of Antigen-specific Tolerance. Mol Ther Methods Clin Dev (2014) 0.93
Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr (2014) 0.88
Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex. J Immunol (2015) 0.88
MiR-152 may silence translation of CaMK II and induce spontaneous immune tolerance in mouse liver transplantation. PLoS One (2014) 0.83
Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection. Int Immunopharmacol (2016) 0.76
Hepatic immune tolerance induced by hepatic stellate cells. World J Gastroenterol (2015) 0.76
Immunological aspects of liver cell transplantation. World J Transplant (2016) 0.75
The CD8 T-cell response during tolerance induction in liver transplantation. Clin Transl Immunology (2016) 0.75
Tumor-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver. Clin Exp Immunol (2016) 0.75
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med (2007) 15.17
The B7 family revisited. Annu Rev Immunol (2005) 13.51
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Lethal effect of the anti-Fas antibody in mice. Nature (1993) 9.20
Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (1995) 8.23
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
The PD-1 pathway in tolerance and autoimmunity. Immunol Rev (2010) 5.99
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity (2004) 4.60
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity (2007) 3.61
Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80
Selective retention of activated CD8+ T cells by the normal liver. J Immunol (1999) 2.23
Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology (2011) 2.14
The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev (2000) 2.13
The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity (1994) 2.11
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut (2009) 2.06
Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology (1988) 2.06
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology (2004) 1.92
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation (1980) 1.71
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology (2006) 1.63
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59
Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52
Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology (2008) 1.49
Isolation and culture of hepatic stellate cells. Methods Mol Med (2005) 1.45
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology (2011) 1.44
Liver transplantation across ABO blood group barriers. Lancet (1990) 1.29
Hepatic stellate cells function as regulatory bystanders. J Immunol (2011) 1.24
Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology (1998) 1.21
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation (2008) 1.20
Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology (2009) 1.16
Negative regulation of T-cell function by PD-1. Crit Rev Immunol (2004) 1.11
Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation (2012) 1.09
Operational tolerance after liver transplantation. J Hepatol (2009) 1.06
The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res (1989) 1.03
Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery (1994) 0.99
Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J Immunol (2012) 0.96
Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology (1998) 0.93
Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction. Transplantation (1998) 0.85
A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery (2010) 0.81
Hepatic antigen-presenting cells and regulation of liver transplant outcome. Immunol Res (2011) 0.79
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl (2002) 2.07
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology (2004) 1.92
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl (2005) 1.79
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology (2006) 1.63
Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. J Surg Oncol (2012) 1.63
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg (2012) 1.56
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol (2012) 1.56
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol (2011) 1.50
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology (2011) 1.44
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol (2002) 1.32
Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol (2006) 1.27
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl (2004) 1.22
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation (2008) 1.20
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol (2002) 1.17
Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology (2009) 1.16
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes (2003) 1.15
Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol (2006) 1.12
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl (2002) 1.11
Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation (2012) 1.09
Immunosuppressive effects of glucosamine. J Biol Chem (2002) 1.08
Interaction between Rice stripe virus disease-specific protein and host PsbP enhances virus symptoms. Mol Plant (2013) 1.07
Dental health status of liver transplant candidates. Liver Transpl (2007) 1.05
Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB (Oxford) (2005) 1.04
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunol (2012) 1.02
Transcriptome analysis of Chlamydomonas reinhardtii during the process of lipid accumulation. Genomics (2013) 1.02
Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation (2002) 0.99
Themes of liver transplantation. Hepatology (2010) 0.98
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience. Transplantation (2004) 0.97
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl (2003) 0.97
Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today (2002) 0.95
Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation (2007) 0.95
The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery (2011) 0.95
Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg (2011) 0.95
Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation (2004) 0.94
The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol (2013) 0.92
Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg (2011) 0.92
Caroli's disease and orthotopic liver transplantation. Liver Transpl (2006) 0.92
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood (2013) 0.92
Differential modulation of CD4 and CD8 T-cell proliferation by induction of nitric oxide synthesis in antigen presenting cells. Transplantation (2002) 0.92
Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med J (2012) 0.91
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg (2005) 0.91
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Preoperative estimation of the liver graft weight in adult right lobe living donor liver transplantation using maximal portal vein diameters. Liver Transpl (2011) 0.90
Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl (2011) 0.90
Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model. Exp Hematol (2009) 0.90
A comparative study on suture versus cuff anastomosis in mouse cervical cardiac transplant. Exp Clin Transplant (2010) 0.90
Metabolic Signatures of Kidney Yang Deficiency Syndrome and Protective Effects of Two Herbal Extracts in Rats Using GC/TOF MS. Evid Based Complement Alternat Med (2013) 0.90
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol (2002) 0.89
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
Cotransplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery (2007) 0.89
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation (2005) 0.89
Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol (2009) 0.88
Graded function of CD80 and CD86 in initiation of T-cell immune response and cardiac allograft survival. Transpl Int (2007) 0.88
Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2012) 0.88
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl (2003) 0.88